J&J Changes ‘Compassionate’ Care

Originally posted in the Wall Street Journal by Jonathan D. Rockoff  Under increasing pressure to expand access to experimental medicines, Johnson & Johnson has arranged for an independent panel to review requests from seriously ill patients who want to try an unapproved drug even if they aren’t participating in the drug’s testing. The committee of […]

Read More

Company Creates Bioethics Panel on Trial Drugs

Originally posted in the New York Times by Katie Thomas Johnson & Johnson has appointed a nationally known bioethicist to create a panel that will make decisions about patients’ requests for potentially lifesaving medicine, responding to an emotional debate over whether companies should allow desperately ill people to have access to the drugs before they […]

Read More

Tomorrow’s Cures Today: Let’s liberate medicine in America. Here’s our vision of health for the 21st Century

Originally posted in Fox News by Bartley J. Madden and James P. Pinkerton Expediting the development and delivery of medical treatments—treatments that bring a new standard of care, or even actual cures for serious illnesses—should be a bipartisan goal, a mission of mercy that should be undertaken by both political parties. We are both involved […]

Read More
Page 5 of 9« First...34567...Last »